Impact of Adding Instrument-assisted Soft Tissue Mobilization to Mulligan Therapy in Patients With Cervicogenic Headache

Обзор

this study will be conducted to investigate the impact of adding Instrument assisted soft tissue mobilization technique to mulligan therapy in patients with cervicogenic headache

Подробное описание

Cervicogenic headache (CGH) has seen a notable rise in prevalence in recent years, substantially impairing patients' daily functioning and occupational productivity. Despite its considerable burden, CGH remains frequently underdiagnosed and inadequately managed, often progressing to a chronic state that heightens the risk of work absenteeism and long-term disability and as the most common type of pain disorders, affecting 66% of the global population, represent a major public health concern due to their detrimental impact on quality of life and economic productivity . Epidemiological data indicate that CGH affects 4.1% of the general population, with prevalence escalating to 17.5% among individuals with severe headaches.Instrument Assisted Soft Tissue Mobilization using Graston (GT®) tool is regarded as one the most advanced and promising methods ,utilizing a specially designed instrument to adress a variety of soft tissue pathologies such as myofascial adhesions , scar tissue restriction , tissue thickenings, ridges, fibrotic nodules, crystalline deposits . this technique works by generating a mobilizing effect ,which contributes to pain reduction ,enhanced range of motion and improved overall function.The Mulligan manual technique is considered one of the most effective forms of manipulations. In contrast to conventional mobilization, which depends entirely on the therapist, Mulligan proposed that applying pressure to the spinous processes while the patient is in a weight-bearing position would cause the facet joints to glide in a coordinated ,parallel direction . simultaneously ,this approach involve the patient's active participation during movemwnt in order to achieve the perfect therapeutic outcomes

Вмешательства

• Другое instrumeted assissted soft tissue mobilization and mulligan therapy
  the patients will receive IASTM tools over the length of targeted muscles (descending fiber of trapezius, suboccipitalis muscles ) for 5 minutes. also, SNAG technique; Each patient will be asked to sit comfortably, and the treating therapist will stand beside the patient. The patient's head will be free and cradled between the therapist's right forearm and body, and the therapist stand at the patient's right side. The therapist then will place his right index, middle, and ring fingers at the bas
• Другое mulligan therapy
  SNAG technique; Each patient will be asked to sit comfortably, and the treating therapist will stand beside the patient. The patient's head will be free and cradled between the therapist's right forearm and body, and the therapist stand at the patient's right side. The therapist then will place his right index, middle, and ring fingers at the base of the occiput and kept his right little finger over the spinous process of C2. Next, with the lateral border of his left thenar eminence, gentle pres
• Другое postural correction exercises
  the exercises will incluse, Stretching exercises for the sternocleidomastoids,the Scalenes,upper fibers of trapezius and strengthening exercises for cervical muscles

Первичные конечные точки

• neck disability [Срок оценки: up to 6 weeks]

Вторичные конечные точки (6)

• pain intensity [Срок оценки: up to 6 weeks]
• cervical range of motion [Срок оценки: up to six weeks]
• muscle stiffness [Срок оценки: up to six weeks]
• headache frequency [Срок оценки: up to six weeks]
• headache duration [Срок оценки: up to six weeks]
• medication intake [Срок оценки: up to 6 weeks]

Критерии участия

Критерии включения

-Unilateral CGH presentation

• Age group above 18 years' old
• History of chronic CGH (>3 months)
• CGH owing to cervical spine (neck) dysfunction
• Reduced cervical motion
• Neck stiffness and movement restriction

Критерии исключения

• Participants with other types of headache (migraine headache)
• Headache owing to other causes (sinus, tumor, neural, and tempero-mandibular joint issues)
• Any contraindications to manual and manipulative therapy (fracture, instability, osteoporosis and neural symptoms)
• Taking analgesics or corticosteroids and migraine-specific medications, such as triptans
• Metastasis
• Cardiac conditions (stroke and syncope)
• Neurological conditions (radiculopathy, myelopathy)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT07373912 · P.T.REC/012/006193

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗